H.R. 3537 — Introduced in House

I 114th CONGRESS 1st Session H. R. 3537 IN THE HOUSE OF REPRESENTATIVES September 17, 2015 Mr. Dent (for himself, Mr. Himes, Mr. Meehan, Mr. Dold, Mr. Tiberi, Mr. Costello of Pennsylvania, Mr. Hanna, Mr. Thompson of Pennsylvania, Mr. Rogers of Kentucky, Mr. Murphy of Pennsylvania, Mr. Barletta, Ms. Norton, Mr. Lance, Mrs. Comstock, Mr. Katko, Ms. Ros-Lehtinen, and Mr. Jolly) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes. 1. Short title This Act may be cited as the Synthetic Drug Control Act of 2015. 2. Controlled substance analogues (a) Expansion of definition (1) In general Clauses (i), (ii), and (iii) of section 102(32)(A) of the Controlled Substances Act (21 U.S.C. 802(32)(A)) are amended by striking substantially each place it appears. (2) Rule of construction Section 102(32)(A) of the Controlled Substances Act (21 U.S.C. 82(32)(A)) shall not be construed to require that a substance satisfy more than one of the clauses listed in such section 102(32)(A) to meet the definition of a controlled substance analogue. (b) Limitation on treatment as controlled substances Section 203 of the Controlled Substances Act (21 U.S.C. 813) is amended by inserting before the period at the end the following: for purposes of prohibitions, restrictions, and other requirements with respect to manufacture, importation, distribution, and sale. 3. Treatment of certain designer drugs as schedule I controlled substances (a) In general Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following: (e) (1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a substances listed in paragraphs (2) through (10), or which contains the salts, isomers, and salts of isomers thereof whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. (2) Phenylalkylamines The substances listed in this paragraph consist of the following phenylalkylamines: (A) 2–(ethylamino)–1–(4-methylphenyl)–1-propanone. (B) 1–(4-ethylphenyl)–2–(methylamino)–1-propanone. (C) 1–(3-fluorophenyl)–2–(methylamino)–1-propanone. (D) 1–(4-fluorophenyl)–2–(methylamino)–1-propanone. (E) 1–(4-methoxyphenyl)–2–(methylamino)–1-propanone. (F) 2–(ethylamino)–1–(4-methoxyphenyl)–1-propanone. (G) 1–(2-naphthalenyl)–2–(1-pyrrolidinyl)–1-pentanone. (H) 1–(1,3-benzodioxol-5-yl)–2–(ethylamino)–1-propanone. (I) 1–(1,3-benzodioxol-5-yl)–2–(methylamino)–1-butanone. (J) 1–(1,3-benzodioxol-5-yl)–2–(methylamino)–1-pentanone. (K) 2–(ethylamino)–1-phenyl-1-propanone. (L) 1-phenyl-2–(1-pyrrolidinyl)–1-propanone. (M) 1–(4-methylphenyl)–2–(1-pyrrolidinyl)–1-propanone. (N) 1–(4-methoxyphenyl)–2–(1-pyrrolidinyl)–1-propanone. (O) 1–(1,3-benzodioxol-5-yl)–2–(1-pyrrolidinyl)–1-propanone. (P) 1-phenyl-2–(1-pyrrolidinyl)–1-pentanone. (Q) 2-amino-1–(4-fluoro)–1-propanone. (R) 2–(methylamino)–1-phenyl-1-pentanone. (S) 2–(ethylamino)–1–(4-ethylphenyl)–1-propanone. (T) 2–(dimethylamino)–1-phenyl-1-propanone. (U) 1–(1,3-benzodioxol-5-yl)–2–(1-pyrrolidinyl)–1-butanone. (V) 1–(methylphenyl)–2–(1-pyrrolidinyl)–1-hexanone. (W) 2–(methylamino)–1-phenyl-1-butanone. (X) 2–(methylamino)–1-p-tolyl-1-butanone. (Y) 1–(4-methylphenyl)–2–(1-pyrrolidinyl)–1-butanone. (Z) 1–(3,4-dimethylphenyl)–2–(methylamino)–1-propanone. (AA) 1-phenyl-2–(1-pyrrolidinyl)–1-butanone. (BB) 1–(1,3-benzodioxol-5-yl)–2–(dimethylamino)–1-propanone. (CC) 1–(4-methylphenyl)–2–(benzylamino)–1-propanone. (DD) 1–(1-naphthy)–2–(1-pyrrolidinyl)–1-pentanone. (EE) 1–(1,3-benzodioxol-5-yl)–2–(benzylamino)–1-propanone. (FF) 1–(1,3-benzodioxol-5-yl)–2–(benzylamino)–1-butanone. (GG) 1–(1,3-benzodioxol)–2-[hydroxy(methyl)-amino]-1-propanone. (HH) 1–(1,3-benzodioxol-5-yl)–2–(dimethylamino)–1-butanone. (II) 2–(ethyl(methyl)amino)–1-phenyl-butanone. (JJ) 1–(4-bromophenyl)–2–(methylamino)–1-propanone. (KK) 2–(ethyl(methyl)amino-1-phenyl-1-propanone. (LL) 2–(methylamino)–1-m-tolyl-1-propanone. (MM) 2–(pyrrolidin-1-yl)–1–(thiophen-2-yl)–1-pentanone. (NN) 1–(4-fluorophenyl)–2–(methylamino)–1-butanone. (OO) 1–(4-methoxyphenyl)–2–(pyrrolidin-1-yl)–1-butanone. (PP) 1–(4-ethylphenyl)–2–(pyrrolidin-1-yl)–1-butanone. (QQ) 1–(4-methoxy-3-methylphenyl)–2–(methylamino)–1-propanone. (RR) 2–(ethylamino)–1–(3-methylphenyl)–1-propanone. (SS) 2-amino-(1H-indol-5-yl)propan-1-one. (TT) 1-phenyl-2–(piperidin-1-yl)butan-1-one. (UU) 2-methylamino-1–(2,4,5-trimethylphenyl)-propan-1-one). (VV) 1-phenyl-2–(pyrrolidin-1-yl)heptan-1-one. (WW) 1-phenyl-2–(pyrrolidin-1-yl)hexan-1-one. (XX) 1–(4-fluorophenyl)–2–(pyrrolidin-1-yl)pentan-1-one. (YY) 1–(benzo[d][1,3]dioxol-5-yl)–2–(dimethylamino)pentan-1-one. (ZZ) 1–(2-fluorophenyl)–N-methyl-propan-2-amine. (AAA) 1–(2-fluorophenyl)-propan-2-amine. (BBB) 1–(3-fluorophenyl)- propan-2-amine. (CCC) 1–(3-fluorophenyl)–N-methyl-propan-2-amine. (DDD) 1–(4-fluorophenyl)- propan-2-amine. (EEE) 1–(4-fluorophenyl)–N-methyl-propan-2-amine. (FFF) 1–(4-methylphenyl)propan-2-amine. (GGG) N-ethyl-N-methyl-1-phenylpropan-2-amine. (HHH) 1–(benzofuran-4-yl)propan-2-amine. (III) 1–(benzofuran-5-yl) propan-2-amine. (JJJ) 1–(2,3-dihydrobenzofuran-5-yl)proan-2-amine. (KKK) 1–(benzofuran-6-yl)- propan-2-amine. (LLL) 1–(2,3-dihydrobenzofuran-6-yl)proan-2-amine. (MMM) 1–(4-methoxyphenyl)–N-methyl-propan-2-amine. (NNN) N,N-dimethyl-1-phenylpropan-2-amine. (OOO) 1–(2,3-dihydro-1H-inden-5-yl)propan-2-amine. (PPP) 5,6,7,8-tetrahydrobenzo[1,3]-benzodioxol-7-amine. (QQQ) a-methyl-4–(methylthio)-benzene-ethanamine. (RRR) 1–(4-chlorophenyl)-propan-2-amine. (SSS) 1–(2,4,6-trimethoxyphenyl)-propan-2-amine. (TTT) 1–(2,4,5-trimethoxyphenyl)-propan-2-amine. (UUU) 1–(2,5-dimethylphenyl)-propan-2-amine. (VVV) 1–(3,4-dimethylphenyl)-propan-2-amine. (WWW) N–(1-phenylpropan-2-yl)propan-1-amine. (XXX) 4–(2-aminopropyl)phenol. (YYY) 3,4-methylenedioxy-N,N-dimethyl-amphetamine. (ZZZ) N-ethyl-1–(4-methoxyphenyl)propan-2-amine. (AAAA) 1–(benzofuran-5-yl)–N-methylpropan-2-amine. (BBBB) 6,7-dihydro-5H-inden[5,6-d][1,3]dioxol-6-amine. (CCCC) 5-iodo-2,3-dihydro-1H-inden-2-amine. (DDDD) 2,3-dihydro-1H-inden-2-amine. (EEEE) 5-methoxy-6-methyl-2,3-dihydro-1H-inden-2-amine. (FFFF) N-methyl-6,7-dihydro-5H-cyclopenta[1,3]-benzodioxol-6-amine. (GGGG) N-methyl-2,3-dihydro-1H-inden-2-amine. (HHHH) 2-[4–(2-fluoroethylthio)–2,5-dimethoxyphenyl]ethanamine. (IIII) 8-bromo-2,3,6,7-tetrahydro-benzo[1,2-b;4,5-b’]difuran-4-ethanamine. (JJJJ) 4-iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)-methyl-benzene-ethamine. (KKKK) 2–(4-chloro-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine. (LLLL) 2–(2,5-dimethoxy-3,4-dimethylphenyl)-ethanamine. (MMMM) 2–(4-methyl-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine. (NNNN) 2–(4-ethyl-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine. (OOOO) 2–(2,5-dimethoxy-3,4-dimethylphenyl)–N–(2-methoxybenzyl)-ethanamine. (PPPP) 2–(2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine. (QQQQ) 2–(4-bromo-2,5-dimethoxyphenyl)–N–(2-methoxybenzyl)-ethanamine. (RRRR) 2–(2,5-dimethoxyphenyl-4-nitro)–N-[(2-methoxyphenyl)methyl]-ethanamine. (SSSS) 1–(4-iodo-2,5-dimethoxyphenyl)propan-2-amine. (TTTT) 1–(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine. (UUUU) 1–(4-chloro-2,5-dimethoxyphenyl)propan-2-amine. (VVVV) 1–(4-bromo-2,3,6,7-terahydrofuro[2,3-f]benzofuran-8-yl)propan-2-amine. (WWWW) (2,5-dimethoxyphenyl)-propan-2-amine. (XXXX) 1-[4–(ethylthio)–2,5-dimethoxyphenyl)propan-2-amine. (YYYY) 1–(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine. (ZZZZ) 1-[2,5-dimethoxy-4–(propylthio)phenyl]propan-2-amine. (AAAAA) 1–(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine. (BBBBB) N-benzyl-2-phenylethanamine. (CCCCC) N,N-dimethyl-2-phenylethanamine. (DDDDD) 6-chloro-aminotetralin. (EEEEE) 2-phenyl-propan-1-amine. (FFFFF) 2-phenethylamine. (GGGGG) 1-methylamino-1–(3,4-methylendioxy-phenyl)propane. (HHHHH) N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine. (IIIII) 1–(2-methoxyphenyl)–N-methylpropan-2-amine. (JJJJJ) 2–(4–(allyloxy)–3,5-dimethoxyphenyl)ethanamine. (KKKKK) 4-methylhexan-2-amine. (LLLLL) 4-methyl-5-phenyl-2-amino-oxazoline. (MMMMM) N-methyl-1-thiophen-2-yl)propan-2-amine. (NNNNN) (3-dimethylamino-2,2-dimethylpropyl)–4-aminobenzoate. (OOOOO) 1–(4-fluorophenyl)–2–(methylamino)-propan-1-ol. (PPPPP) 4-methyl-5-p-tolyl-4,5-dihydrooxazol-2-amine. (QQQQQ) 1-phenyl-2–(pyrrolidin-1-yl)propan-1-ol. (3) Cannabimimetic agents The substances listed in this paragraph consist of the following cannabimimetic agents: (A) (4-ethyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone. (B) 2–(2-methylphenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone. (C) 1-[1–(2-cyclohexylethyl)–1H-indol-3-yl]-2–(2-methoxyphenyl)-ethanone. (D) [1–(5-fluoropentyl)–1H-indol-3-yl](2-iodophenyl)methanone. (E) (2-methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl)methanone. (F) (1-butyl-1H-indol-3-yl)(4-methoxyphenyl)-methanone. (G) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone. (H) [1–(5-fluoropentyl)–1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone. (I) [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone. (J) 3–(4-methoxyphenyl)–2-methyl-1-[(2–(4-morpholinyl)ethyl)–1H-indol-3-yl]-methanone. (K) [2,3-dihydro-5-methyl-3–(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl- methanone. (L) 2–(3-methoxyphenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone. (M) (2-iodophenyl)[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-methanone. (N) [1-[(1-methyl-2-piperdinyl)methyl]-1H-indol-3-yl]tricycle[3.3.1.13,7]dec-1-yl-methanone. (O) 1-naphthalenyl(1-propyl-1H-indol-3-yl)-methanone. (P) 5-[3–(1-naphthoyl)–1H-indole-1-yl]pentanenitrile. (Q) 3–(1-naphthenylmethyl)–1-pentyl-1H-indole. (R) (2-methyl-1-propyl-1H-indol-3-yl)–1-napthalenyl-methanone. (S) 1-naphthalenyl[1–(4-penten-1-yl)–1H-indol-3-yl]-methanone. (T) (4-bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone. (U) (4-fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone. (V) (2-methyl-1-phenyl-1H-indol-3-yl)–1-naphthalenyl-methanone. (W) 2–(2-chlorophenyl)–1–(1-pentyl-1H-indol-3-yl)-ethanone. (X) [1–(5-chloropentyl)–1H-indol-3-yl](2-iodophenyl)-methanone. (Y) (adamantan-1-yl)(1-pentyl-1H-indol-3-yl)-methanone. (Z) (2-iodo-5-nitrophenyl)-[1–(1-methylpiperidin-2-ylmethyl)–1H-indol-3-yl]-methanone. (AA) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclo-propyl)methanone. (BB) [1–(5-fluoropentyl-1H-indol-3-yl)](2,2,3,3-tetramethylcyclo-propyl)methanone. (CC) [1–(2-morpholinoethyl)–1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (DD) 1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-3-yl-(2,2,3,3-tetramethylcyclopropyl)methanone. (EE) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide. (FF) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide. (GG) 1–(5-fluoropentyl)–N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide. (HH) [1–(5-chloropentyl)–1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (II) (1-isopentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone. (JJ) 1–(5-fluoropentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide. (KK) (1-pentyl-1H-indol-3-yl)(4-propyl-1-naphthalenyl)-methanone. (LL) [1–(5-chloropentyl)–1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (MM) (4-methyl-naphthalen-1-yl)[1–(pent-4-en-1-yl)–1H-indol-3-yl]methanone. (NN) (2-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone. (OO) (3-methoxy-phenyl)(1-pentyl-1H-indol-3-yl)methanone. (PP) [1–(5-fluoropentyl)–1H-indol-3-yl](4-ethyl-1-naphthalenyl)-methanone. (QQ) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. (RR) quinolin-8-yl 1–(5-fluoropentyl-1H-indole-3-carboxylate. (SS) 1–(cyclohexylmethyl)–8-quinolinyl-ester-1H-indole-3-carboxylic acid. (TT) N–(1-amino-3-methyl-1-oxobutan-2-yl)–1-pentyl-1H-indazole-3-carboxamide. (UU) 1–(5-fluoropentyl)–N–(naphthalene-1-yl)–1H-indole-3-carboxamide. (VV) N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide. (WW) N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide. (XX) N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1-pentyl-1H-indole-3-carboxamide. (YY) 2-iodophenyl)(1-pentyl-1H-indol-3-yl)methanone. (ZZ) [5–(2-methylphenyl)–1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone. (AAA) 1-pentyl-N–(naphthalene-1-yl)–1H-indole-3-carboxamide. (BBB) 1–(5-chloropentyl)–1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone. (CCC) (4-methyl-naphthalen-1-yl)[2-methyl-1–(pent-4-en-1-yl)–1H-indol-3-yl)]methanone. (DDD) [1–(5-fluoropentyl)–1H-indol-3-yl](o-tolyl)methanone. (EEE) (2-ethylphenyl)(1–(5-fluoropentyl)–1H-indol-3-yl)methanone. (FFF) [1–(5-chloropentyl)–1H-indol-3-yl](naphthalen-1-yl)methanone. (GGG) [1–(5-bromopentyl)–1H-indol-3-yl](naphthalen-1-yl)methanone. (HHH) (1–(5-fluoropentyl)–1H-indazol-3-yl)(naphthalene-1-yl)methanone. (III) 1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (JJJ) (1–(1-methylazepan-2-yl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone. (KKK) 4-hydroxy-3,3,4-trimethyl-1–(1-pentyl-1H-indol-3-yl)pentan-1-one. (LLL) [1–(4-fluoropentyl)–1H-indol-3-yl]-1-naphthenyl-methanone. (MMM) 2–(2-iodophenyl)–1–(1-pentyl-1H-indol-3-yl)ethanone. (NNN) (1-hexyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone. (OOO) (2,2,3,3-tetramethylcyclopropyl)[1–(4,4,4-trifluorobutyl)–1H-indol-3-yl]methanone. (PPP) 7-methoxy-1–(2-morpholinoethyl)–N–((1S,4R)–1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)–1H-indole-3-ca rboxamide. (QQQ) quinolin-8-yl 1–(4-fluorobenzyl)–1H-indole-3-carboxylate. (RRR) naphthalen-1-yl 1–(4-fluorobenzyl)–1H-indole-3-carboxylate. (SSS) N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1-pentyl-1H-indazole-3-carboxamide. (TTT) N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide. (UUU) (1–(4-fluoropentyl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone. (VVV) 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)methanone. (WWW) N-naphthalenyl-1-pentyl-1H-indazole-3-carboxamide. (XXX) N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(cyclohexyl methyl)–1H-indazole-3-carboxamide. (YYY) naphthalene-1-yl(9-pentyl-9H-carbazol-3-yl)methanone. (ZZZ) naphthalene-1-yl 1–(5-fluoropentyl)–1H-indole-3-carboxylate. (AAAA) methyl 3-methyl-2–(1-pentyl-1H-indazole-3-carboxamido. (BBBB) methyl 2–(1–5-fluoropentyl)–1H-indazole-3-caboxamido)–3-methylbutanoate. (CCCC) N-benzyl-1-pentyl-1H-indole-3-carboxamide. (DDDD) N-benzyl-1–(5-fluoropentyl)–1H-indole-3-carboxamide. (EEEE) methyl 2–(1–(4-fluorobenzyl)–1H-indazole-3-carboxamido)–3-methylbutanoate. (FFFF) quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate. (GGGG) quinolin-8-yl 1–(5-fluoropentyl)–1H-indazole-3-carboxylate. (HHHH) naphthalene-2-yl 1–(2-fluorophenyl)–1H-indazole-3-carboxylate. (IIII) N–(1-amino-3,3-dimethyl-1-oxobutan-2-yl)–1–(cyclohexylmethyl)–1H-indazole-3-carboxamide. (JJJJ) (1–(4-flourobenzyl)–1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone. (KKKK) N–(1-amino-1-oxo—3-phenylpropan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide. (LLLL) N–(1-amino-1-oxo—3-phenylpropan-2-yl)–1–(5-fluoropentyl)–1H-indazole-3-carboxamide. (MMMM) methyl (1–(cyclohexylmethyl)–1H-indazole-3-carbonyl-L-valinate. (NNNN) N-[(1–(cyclohexylmethyl)–1H-indazole-3yl)carbonyl]-3-methyl-L-valine, methyl ester. (OOOO) methyl 2–(1–(cyclohexylmethyl)–1H-indole-3-carboxamido)–3,3-dimethylbutanoate. (PPPP) (1–(5-fluoropentyl)–1H-benzo[d]imidazole-2-yl)(naphthalene-1-yl)methanone. (QQQQ) (1–(4-fluorobenzyl)–1H-indol-3-yl)(napthalen-1-yl)methanone. (RRRR) methyl 2–(1–(4-fluorobenzyl)–1H-indazole-3-carboxamido)–3,3-dimethylbutanoate. (SSSS) quinolin-8-yl 1–(4-fluorobenzyl)–1H-indazole-3-carboxylate. (TTTT) N–(adamantan-1-yl)–1–(4-fluorobenzyl)–1H-indazole-3-carboxamide. (UUUU) N–(1-amino-3-methyl-1-oxobutan-2-yl)–1–(5-fluoropentyl)–1H-indole-3-carboxamide. (VVVV) 2-[(1S,3R)–3-hydroxycyclohexyl]-5–(2-methylheptyl-2-yl)phenol. (WWWW) 2-[(1S,3R)–3-hydroxycyclohexyl]-5–(2-methyldodecanyl-2-yl)phenol. (XXXX) 3-hydroxy-2[3-methyl-6–(1-methylethyenyl)–2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione. (YYYY) 4-[4–(1,1-dimethylheptyl)–2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol. (ZZZZ) 1-naphthalenyl[4–(pentylox)–1-naphthalenyl]-methanone. (AAAAA) 3–(2–(hydroxymethyl)–2,3-dihydro-1H-inden-4-yloxy)phenyl 4,4,4-trifluorobutane-1-sulfonate. (BBBBB) N–(benzo[1,3]dioxol-5-ylmethyl)–7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide. (CCCCC) N-[3–(2-methoxyethyl)–4,5-dimethylthiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-carboxamide. (DDDDD) 5-chloro-3-ethyl-N-[4–(piperidin-1-yl)phenethyl)–1H-indole-2-carboximide. (EEEEE) N-[4–(dimethylamino)phenethyl]-3-ethyl-5-fluoro-1H-indole-2-carboximide. (FFFFF) N–(1-benzylpyrrolidin-3-yl)–5-chloro-3-ethyl-1H-indole-2-carboxamide. (GGGGG) [5–(2-fluorophenyl)–1-pentyl-1H-pyrrol-3-yl](naphthalene-1-yl)methanone. (HHHHH) (3’-(aminocarbonyl)[1,1’-biphenyl]-3-yl)-cyclohexyl-carbamate. (IIIII) 5–(biphenyl-4-ylmethyl)–N,N-dimethyl-1H-tetrazole-1-carboxamide. (JJJJJ) 6-methyl-2–(p-tolylamino)–4H-benzo[d][1,3]oxazin-4-one. (KKKKK) [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester. (LLLLL) 4-hydroxy-N–(4-hydroxyphenethyl)–3–(pentylamino)-benzamide. (MMMMM) 3’-carbamoyl-6-hydroxy-[1,1’-biphenyl]-3-yl cyclohexylcarbamate. (4) Arylcyclohexamines The substances listed in this paragraph consist of the following arylcyclohexamines: (A) 1–(3-methoxyphenyl)–N-propylcyclohexan-amine. (B) 2–(ethylamino)–2–(3-methoxyphenyl)cyclohexanone. (C) 1-phenylcyclohexan-amine. (D) 1-[1–(benzothiophen-2-yl)cyclohexyl]piperidine. (E) 1–(1-p-tolylcyclohexyl)-piperidine. (F) 1–(4-methoxyphenyl)–N-propylcyclohexan-amine. (G) 1-[1–(4-methoxyphenyl)cyclohexyl]-piperidine. (H) 1-[1–(3-methoxyphenyl)cyclohexyl]-piperidine. (I) 1-phenyl-N-propylcyclohexanamine. (J) N–(2-methoxyethyl)–1-phenylcyclohexan-amine. (K) N–(2-ethoxyethyl)–1-phenylcyclohexan-amine. (L) N–(3-methoxypropyl)–1-phenylcyclohexan-amine. (M) 3-[1–(piperidin-1-yl)cyclohexyl]-phenol. (N) 2–(methoxyphenyl)–2–(methylamino)cyclohexanone. (O) N-ethyl-1–(thiophen-2-yl)cyclohexanamine. (P) (2–(2-chlorophenyl)–2–(ethylamino)-cyclohexanone). (5) Tryptamines The substances listed in this paragraph consist of the following tryptamines: (A) 2–(1H-indol-3-yl)–N-methyl-ethanamine. (B) N–(2–(1H-indol-3-yl)ethyl-N-methylpropan-2-amine. (C) N-[2–(1H-indol-3-yl)ethyl]-N-isopropylpropan-2-amine. (D) N,N-dipropyl-1H-indole-3-ethanamine. (E) 3-[2–(diethylamino)ethyl]-1H–4yl acetate. (F) 3–(2-[isopropyl(methyl)amino]ethyl)–1H-indol-4-ol. (G) 3-[2–(bis[1-methylethyl]amino)ethyl]-1H-indol-4-ol acetate. (H) 3–(2-[isopropyl(methyl)amino]ethyl)–1H-indol-4-ol acetate. (I) 3-[2–(dimethylamino)ethyl]-1H-indol-4-yl acetate. (J) 4-hydroxy-N,N-diethyl-1H-indole-ethanamine. (K) 4-methoxy-N,N-dimethyl-1H-indole-3-ethanamine. (L) 3–(2–(diisopropylamino)ethyl)–1H-indol-4-ol. (M) 3-[2–(ethyl[methyl]amino)ethyl]-1H-indol-4-ol. (N) 3-[2–(ethyl[methyl]amino)ethyl]-1H-indol-4-yl acetate. (O) 3–(2–(dipropylamino)ethyl)–1H-indol-4-ol. (P) 3-[2–(dipropylamino)ethyl]-1H-indol-4-yl acetate. (Q) 4-acetoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine. (R) 5-methoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine. (S) 3–(2–(dimethylaminoethyl)–1H-indol-5-ol. (T) 2–(5-methoxy-1H-indol-3-yl)–N,N-dimethylethanamine. (U) N-[2–(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropyl. (V) 1–(5-methoxy-1H-indol-3-yl)propan-2-amine. (W) 3-[2–(dimethylamino)-ethyl]-1H-indol-5-yl acetate. (X) N-[2–(5-methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine. (Y) N,N-diethyl-2–(5-methoxy-1H-indol-3-yl)ethanamine. (Z) N-ethyl-2–(5-methoxy-1H-indol-3-yl)–N-methyl-ethanamine. (6) Benzylpiperidines The substances listed in this paragraph consist of the following benzylpiperidines: (A) 2–(diphenylmethyl)-piperidine. (B) 2-benzhydrylpyrrolidine. (C) a,a-diphenyl-(pyrrolidin-2-yl)methanol. (D) methyl 2–(3,4-dichlorophenyl)–2–(piperdin-2-yl)acetate. (E) methyl 2–(3-chlorophenyl)–2–(piperidin-2-yl)acetate. (F) methyl 2–(piperidin-2-yl)–2-p-tolylacetate. (G) methyl 2–(4-fluorophenyl)–2–(piperidin-2-yl)acetate. (H) ethyl 2-phenyl-2–(piperidin-2-yl)acetate. (7) Benzodiazepines The substances listed in this paragraph consist of the following benzodiazepines: (A) 4–(2-chlorophenyl)–2-ethyl-9-methyl-6H-thieno-[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. (B) 7-bromo-5–(2-chlorophenyl)–1H-benzo[e][1,4]diazepin-2(3H)-one. (C) 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine. (D) 3-methyl-6-[3–(trifluoromethyl)phenyl][1,2,4]triazol[4,3-b]pyridazine. (E) 6–(5-chloro-2-pyridyl)–6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate. (8) Opioids and opioid-like substances The substances listed in this paragraph consist of the following opioids and opioid-like substances: (A) 2–(1,3-dimethoxybuta-1,3-dien-2-yl)–3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quin olizine. (B) (2a,4aR,6aR,7R,9S,10aS10bR)-methyl-9-acetoxy-2–(furan-3-yl)–6a,10b-dimethyl-4,10-dioxododecahydro-1 H-benzo[f]isochromene-7-carboxylate. (C) 3,4-dichloro-N–([1–(dimethylamino)cyclohexyl]methyl)benzamide. (D) 3-[2–(amino-1-methylethyl)–1-hydroxycyclohexyl]-phenol. (E) 4,5-epoxy-17-methylmorphinan-3-ol. (F) N-phenyl-N-[1–(2-phenethyl)–4-piperidinyl] acetamide. (G) N–(1-benzylpiperidin-4-yl)–N–(x-fluorophenyl)-butanamide. (H) 2-methyl-N-phenyl-N-[1–(1-phenylpropan-2-yl)piperidin-4-yl]propanamide. (I) N–(1-phenethylpiperidin-4-yl)–N-phenylbutyramide. (J) 1-cyclohexyl-4–(1,2-diphenylethyl)-piperazine. (K) N-phenyl-N–(1–(2–(thiophen-2-yl)ethyl)piperidin-4-yl)acetamide. (L) 4-chloro-N–(1-phenethylpiperidin-2-ylidene)benzenesulfonamide. (M) 4-chloro-N–(1–(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide. (9) Piperazines The substances listed in this paragraph consist of the following piperazines: (A) 1,4-dibenzylpiperazine. (B) 1–(4-bromo-2,5-dimethoxybenzyl)-piperazine. (C) 1–(4-fluorophenyl)-piperazine. (D) 1–(2-methoxyphenyl)-piperazine. (E) 1–(4-chlorophenyl)-piperazine. (F) 1–(4-methoxyphenyl)-piperazine. (G) 1–(3-methylbenzyl)piperazine. (H) 1-benzyl-4-methylpiperazine. (10) Tropane alkaloids The substances listed in this paragraph consist of the following tropane alkaloids: (A) 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 4-fluorobenzoate. (B) methyl 3–(4-fluorophenyl)–8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. . (b) Effective date The amendment made by subsection (a) takes effect on the date that is 30 days after the date of enactment of this Act.